Articles from Talking Medicines

Talking Medicines, the advanced data science and AI company for life sciences, today announced a new intent-to-prescribe application within DrugVoice, enabled through partnerships with point-of-care data providers.

Talking Medicines, a pioneering leader in healthcare intelligence leveraging Advanced Data Science and Artificial Intelligence, is proud to announce a robust start to 2024, marked by record revenue bookings and significant advancements in its innovative platform Talking Medicines Drug-GPT. The Company is headquartered in Glasgow with a growing sales presence in New Jersey/New York/Philadelphia.

Healthcare marketers can now access vital insights about patients and healthcare professionals (“HCPs”) within seconds through the world’s first curated Patient Voice GPT.